Chiasma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Chiasma and buy or sell other stocks, ETFs, and their options commission-free!About CHMA
Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules.
CEORaj Kannan, MBA
CEORaj Kannan, MBA
Employees—
Employees—
HeadquartersNewton Center, Massachusetts
HeadquartersNewton Center, Massachusetts
Founded2001
Founded2001
Employees—
Employees—
CHMA Key Statistics
Market cap237.81M
Market cap237.81M
Price-Earnings ratio-2.35
Price-Earnings ratio-2.35
Dividend yield—
Dividend yield—
Average volume1.23M
Average volume1.23M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.74
52 Week high$5.74
52 Week low$2.77
52 Week low$2.77
Stock Snapshot
With a market cap of 237.81M, Chiasma(CHMA) trades at $3.76. The stock has a price-to-earnings ratio of -2.35.
On 2025-12-31, Chiasma(CHMA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Chiasma(CHMA) stock has reached 0, versus its average volume of 1.23M.
Over the past 52 weeks, Chiasma(CHMA) stock has traded between a high of $5.74 and a low of $2.77.
Over the past 52 weeks, Chiasma(CHMA) stock has traded between a high of $5.74 and a low of $2.77.
People also own
Based on the portfolios of people who own CHMA. This list is generated using Robinhood data, and it’s not a recommendation.